MediWound Reports Third Quarter 2017 Financial Results
NexoBrid® sales grow 74% year-to-date Raised gross proceeds of $25.2 million through public equity offering Awarded additional $32 million from BARDA to support NexoBrid R&D programs Conference call begins today at 8:30 a.m. Eastern Standard Time YAVNE …